Glooko Scores $100 Million Series F

<p><strong>PALO ALTO<&sol;strong> &&num;8212&semi; Glooko&comma; Inc&period;&comma; a digital health company connecting patients&comma; providers&comma; biopharma and medical device partners&comma; has secured a &dollar;100 million Series F round&period; The Company’s Board of Directors also announced the appointment of Mike Alvarez as Chief Executive Officer&period;<&sol;p>&NewLine;<p>The funding round&comma; led by Georgian&comma; with investments from Health Catalyst Capital&comma; Canaan and other investors and business partners&comma; will support Glooko’s continued growth and product expansion in expert data insights&comma; device integrations&comma; clinical research and chronic condition support for healthcare providers around the world&period; This funding&comma; coupled with the appointment of Mr&period; Alvarez as CEO&comma; will allow Glooko to accelerate global product expansion of its cutting-edge digital healthcare platform and life sciences work&comma; which empowers people with diabetes to better manage their condition and strengthen the engagement with and care from their healthcare team&period;<&sol;p>&NewLine;<p>&OpenCurlyDoubleQuote;On behalf of the Board of Directors&comma; we are delighted to welcome Mike Alvarez as the new leader of Glooko&comma;” said Simon Chong&comma; Co-Founder at Georgian and Chairman of the Board of Directors for Glooko&period; &OpenCurlyDoubleQuote;Today&comma; more than 537 million adults worldwide are diagnosed with diabetes&comma; and the numbers are projected to grow every year&period; The need for timely&comma; comprehensive and integrated support for healthcare practitioners is critical&period; Mike brings significant industry expertise&comma; proven leadership and commercial success across chronic condition management and population health&comma; as well as experience with advanced data management technologies&period; We believe Mike is the right leader at a key inflection point for Glooko and look forward to working with him&period;”<&sol;p>&NewLine;<p>Mr&period; Alvarez brings more than two decades of leadership experience with multinational companies in medical devices and biotechnology&period; Most recently&comma; Mr&period; Alvarez served as Chief Executive Officer of Qardio&comma; a leader in remote patient monitoring and technology solutions for chronic disease management&period; Prior to Qardio&comma; Mr&period; Alvarez held leadership positions at Medtronic&comma; St&period; Jude Medical &lpar;acquired by Abbott&rpar;&comma; and Sanofi&period;<&sol;p>&NewLine;<p>&OpenCurlyDoubleQuote;The healthcare industry is currently navigating significant challenges related to data burden and clinical workflows&comma; particularly for physicians working with patients to manage chronic conditions&comma;” said Mr&period; Alvarez&period; &OpenCurlyDoubleQuote;By unifying data from multiple devices onto one standardized platform&comma; we can simplify decision-making and empower providers to translate vast amounts of data into meaningful insights&period; This enables timely interventions and helps create new clinical care pathways that can enhance patient outcomes&period; I am thrilled to join Glooko at this pivotal moment in its journey&period; I look forward to continued commercial acceleration as we leverage real-world data to transform chronic condition management and improve enrollment and management in clinical trials through diverse and inclusive populations&period;”<&sol;p>&NewLine;